Implied BIB Analyst Target Price: $63
Wed, Aug 23, 8:54 AM ET, by ETF Channel
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $62.80 per unit.
With BIB trading at a recent price near $53.27 per unit, that means that analysts see 17.88% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of BIB's underlying holdings with notable upside to their analyst target prices are Retrophin, Inc. (RTRX), Ophthotech Corp (OPHT), and Teligent Inc (TLGT). Although RTRX has traded at a recent price of $23.91/share, the average analyst target is 58.93% higher at $38.00/share. Similarly, OPHT has 55.11% upside from the recent share price of $2.74 if the average analyst target price of $4.25/share is reached, and analysts on average are expecting TLGT to reach a target price of $9.80/share, which is 51.00% above the recent price of $6.49. Below is a twelve month price history chart comparing the stock performance of RTRX, OPHT, and TLGT:
Below is a summary table of the current analyst target prices discussed above:
|Name ||Symbol ||Recent Price ||Avg. Analyst 12-Mo. Target ||% Upside to Target|
|ProShares Ultra Nasdaq Biotechnology ETF ||BIB ||$53.27 ||$62.80 ||17.88%|
|Retrophin, Inc. ||RTRX ||$23.91 ||$38.00 ||58.93%|
|Ophthotech Corp ||OPHT ||$2.74 ||$4.25 ||55.11%|
|Teligent Inc ||TLGT ||$6.49 ||$9.80 ||51.00%|
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on RTRX — FREE
Get the latest Zacks research report on OPHT — FREE
Get the latest Zacks research report on TLGT — FREE
Read the original article at ETF Channel: Implied BIB Analyst Target Price: $63
SDI Glossary: "Analyst" Definition
SDI Glossary: "Channel" Definition
SDI Glossary: "price" Definition
SDI Glossary: "ETFs" Definition
This Article's Word Cloud:
More articles: 1 2 3 4 5 6 7 next »